Literature DB >> 29454467

Microvascular decompression for hemifacial spasm: Outcome on spasm and complications. A review.

M Sindou1, P Mercier2.   

Abstract

Over the last decades microvascular decompression (MVD) has been established as the curative treatment of the primary Hemifacial Spasm (HFS), proven to be linked in almost all cases to a neurovascular compression of the facial nerve. Because the disease is not life-threatening and MVD not totally innocuous, efficacy and safety have to be weighted before decision taken of indicating surgery. The authors have been charged by the French Speaking Society of Neurosurgery to conduct a detailed evaluation of the probability of relief of the spasm that MVD is able to obtain, together with its potential complications. For the review, the authors have gone through the reports available from the Pubmed system. Eighty-two publications have been read and analysed, totalizing more than 10,000 operated cases. In most series, the percentage of patients with total relief ranged between 85% and 90%. Relief was obtained after a certain delay in as many as in 33%±8% of the patients in many series. For those, delay lasted around one year in 12% of them. When effect of MVD was considered achieved, relief remained permanent in all but 1%-2% of the long-term followed patients. As regards to complications, risk of permanent cranial nerve deficit was evaluated at 1%-2% for facial palsy, 2%-3% for non-functional hearing loss, 0.5%-1% for lower cranial nerve dysfunction. Risk of stroke was at 0.1% and mortality at 0.1%. CSF leakage and related complications could be reduced at less than 2% in most series provided careful closing techniques be applied. Complications were at a higher rate in repeated MVD. MVD is an effective curative method for almost all the patients affected with primary HFS. Because MVD for HFS is functional surgery, scrupulous consideration of its potential risks, together with the ways to avoid complications are of paramount importance. When MVD is estimated to have failed, it is wise to wait one year before considering to repeat surgery, as number of patients may benefit from delayed effect. This is the more so as important as repeated surgery entails a higher rate of complications.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Complications; Hemifacial spasm; Microvascular decompression; Outcome

Mesh:

Year:  2018        PMID: 29454467     DOI: 10.1016/j.neuchi.2018.01.001

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  11 in total

Review 1.  Nerve Compression Syndromes in the Posterior Cranial Fossa.

Authors:  Jörg Baldauf; Christian Rosenstengel; Henry W S Schroeder
Journal:  Dtsch Arztebl Int       Date:  2019-01-25       Impact factor: 5.594

2.  Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis.

Authors:  David J Cote; Hormuzdiyar H Dasenbrock; William B Gormley; Timothy R Smith; Ian F Dunn
Journal:  World Neurosurg       Date:  2019-05-11       Impact factor: 2.104

3.  Common trunk anomaly of the anterior and posterior inferior cerebellar artery in hemifacial spasm.

Authors:  Yukihiro Goto; Takuro Inoue
Journal:  Acta Neurochir (Wien)       Date:  2022-05-07       Impact factor: 2.216

4.  Association study of the pneumatization degree of mastoid air cells and postoperative complications after microvascular decompression in hemifacial spasm.

Authors:  Jianxin Zhou; Quanhong Shi; Li Jiang; Yanfeng Xie; Bo Deng; Yan Zhan
Journal:  Acta Neurochir (Wien)       Date:  2022-02-21       Impact factor: 2.216

5.  Hearing Outcomes after Microvascular Decompression for Hemifacial Spasm: An Institutional Experience.

Authors:  Ambuj Kumar; Ahmed Ansari; Yasuhiro Yamada; Tsukasa Kawase; Yoko Kato
Journal:  Asian J Neurosurg       Date:  2020-04-07

6.  Roles of preoperative anxiety and depression in the outcomes of microvascular decompression in hemifacial spasm for adolescent patients.

Authors:  Fan Wu; Pingcun Wei; Gang Wang; Changsong Wu; Yunlong Hu; Jinwang Hu
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

7.  Prevalence and severity of neurovascular compression in hemifacial spasm patients.

Authors:  Katie S Traylor; Raymond F Sekula; Komal Eubanks; Nallammai Muthiah; Yue-Fang Chang; Marion A Hughes
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

8.  The outcome of microvascular decompression for hemifacial spasm: a systematic review and meta-analysis.

Authors:  Jianguo Li; Liang Lyu; Cheng Chen; Senlin Yin; Shu Jiang; Peizhi Zhou
Journal:  Neurosurg Rev       Date:  2022-01-20       Impact factor: 3.042

9.  Facial root entry/exit zone contact in microvascular decompression for hemifacial spasm: a historical control study.

Authors:  Xianxia Yan; Chengwen Ma; Junxiang Gu; Jianqiang Qu; Junjie Quan; Xi Zhang; Qin Song; Le Zhou
Journal:  Ann Transl Med       Date:  2021-05

10.  The eagle jugular syndrome as the cause of delayed intracranial hemorrhage after microvascular decompression for hemifacial spasm: A case report.

Authors:  Takahisa Nonaka; Kiyohiko Sakata; Toshi Abe; Gohsuke Hattori; Kimihiko Orito; Naohisa Miyagi; Takashi Tokutomi; Motohiro Morioka
Journal:  Surg Neurol Int       Date:  2021-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.